|
HS Code |
597730 |
| Chemical Name | Dopamine Hydrochloride |
| Molecular Formula | C8H12ClNO2 |
| Molecular Weight | 189.64 g/mol |
| Appearance | White to off-white crystalline powder |
| Solubility | Freely soluble in water |
| Cas Number | 62-31-7 |
| Storage Temperature | 2-8°C |
| Pharmacological Class | Adrenergic and dopaminergic agonist |
| Route Of Administration | Intravenous |
| Mechanism Of Action | Stimulates dopamine, beta1-adrenergic, and alpha-adrenergic receptors |
| Indications | Treatment of shock and low blood pressure |
| Half Life | About 2 minutes |
| Brand Names | Intropin |
| Manufacturer | Various |
| Contraindications | Pheochromocytoma, uncorrected tachyarrhythmias |
As an accredited Dopamine Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Dopamine Hydrochloride, 5g, supplied in a sealed amber glass vial with tamper-evident cap, labeled with hazard and handling information. |
| Shipping | Dopamine Hydrochloride is shipped in tightly sealed containers, protected from light and moisture. It is classified as a non-hazardous chemical for air and ground transport but should be handled with care. Packaging complies with international and local regulations, ensuring safe transit and storage at controlled room temperatures. |
| Storage | Dopamine Hydrochloride should be stored in a tightly closed container, protected from light and moisture. Keep it at a temperature between 2°C and 8°C (refrigerated). Avoid exposure to excessive heat and incompatible substances. Ensure the storage area is well-ventilated and restrict access to authorized personnel. Follow all applicable regulations and guidelines for handling and storage of pharmaceuticals and chemicals. |
|
Purity 98%: Dopamine Hydrochloride with 98% purity is used in pharmaceutical synthesis, where it ensures high-yield bioactive compound formation. Molecular Weight 189.64 g/mol: Dopamine Hydrochloride of molecular weight 189.64 g/mol is used in neurochemical research, where it enables accurate receptor binding studies. Melting Point 248°C: Dopamine Hydrochloride with a melting point of 248°C is utilized in controlled-release drug formulations, where it provides thermal stability during processing. Stability in Aqueous Solution: Dopamine Hydrochloride with high aqueous stability is used in intravenous infusions, where it maintains consistent pharmacological efficacy. Particle Size <50 µm: Dopamine Hydrochloride with particle size less than 50 µm is used in injectable preparations, where it ensures rapid dissolution and bioavailability. Endotoxin Level <0.1 EU/mg: Dopamine Hydrochloride with endotoxin level below 0.1 EU/mg is used in sterile pharmaceutical manufacturing, where it minimizes immunogenic responses. USP Grade: Dopamine Hydrochloride of USP grade is used in regulatory-compliant drug development, where it guarantees conformity to quality standards. Storage Temperature 2-8°C: Dopamine Hydrochloride requiring storage at 2-8°C is used in clinical laboratories, where it preserves chemical integrity over extended periods. Solubility >100 mg/mL in Water: Dopamine Hydrochloride with solubility greater than 100 mg/mL in water is used in parenteral solutions, where it facilitates concentrated dosing protocols. Optical Rotation +13° to +15°: Dopamine Hydrochloride with optical rotation between +13° and +15° is used in chiral purity assessment, where it confirms enantiomeric composition. |
Competitive Dopamine Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Dopamine Hydrochloride has become an essential component in hospital medicine cabinets, especially in critical care environments. It did not just show up overnight—it earned its place by doing what other vasoactive drugs struggle with: restoring blood flow during acute low blood pressure, shock, or failing circulation, often caused by trauma or severe infection. For those caring for people in intensive care or emergency situations, Dopamine Hydrochloride stands out for its targeted action and reliability. Over decades, it built its reputation through clinical experience and research studies, not just because it briefly stimulates blood pressure but because lives often depend on it.
When I look at Dopamine Hydrochloride, I think about the many ways this medicine offers flexibility. Given through intravenous infusion, healthcare workers can titrate the dose minute by minute, adjusting to the needs of newborns or adults without confusion. Its onset is quick, so monitoring response happens in real time. Each vial comes prepared in consistent, sterile strengths—usually in 40 mg/ml concentrations, packaged in amber glass to protect from light. This careful preparation matters; medical staff expect every dose to behave predictably. You cannot afford surprises with someone’s circulation on the line.
It’s easy to see why Dopamine Hydrochloride remains trusted. Backed by decades of study, the medication has withstood direct comparison with newer drugs. Peer-reviewed research supports dosing guidelines for sepsis and cardiac emergencies, and experts review protocols constantly as new data appear. Doctors and nurses gravitate toward treatments that work in the real world—the ICU, the ambulance, or the operating room. That trust owes as much to years of safe experience as to published data, both of which reinforce why hospitals still stock Dopamine Hydrochloride alongside newer alternatives.
Plenty of people ask what makes this drug different from other vasopressors like norepinephrine, epinephrine, or dobutamine. Each works on body chemistry a little differently. Dopamine Hydrochloride stimulates multiple receptors in the body, not just the alpha-adrenergic receptors responsible for squeezing blood vessels. At lower doses, the drug primarily affects dopaminergic and beta-adrenergic receptors—helping the heart pump without raising blood pressure too fast. As the dose increases, it starts to affect alpha-adrenergic receptors, raising blood pressure by making blood vessels contract. With that range of action, doctors can start with mild support and ramp up if needed, all using one medication. In comparison, norepinephrine leans heavily toward raising blood pressure, and dobutamine is used mainly for boosting heart contractility without significant effects on vessel tone. Dopamine Hydrochloride lets critical care and cardiac teams adapt in real time, using evidence from bedside monitors and labs, not guesswork.
You can’t separate the value of a medicine from the way it shows up in pharmacy cabinets. Dopamine Hydrochloride is produced in sterile, stable formulations, shipped in glass amps to maintain purity. Clinicians mix it with standard intravenous fluids, usually sodium chloride or dextrose solutions, depending on complexity of a patient’s needs. What impresses me is the clear labeling and clarity about drug concentration, which avoids errors during high-stress moments. Allergic reactions and serious side effects remain rare, helping preserve a good safety record. Pharmacy teams rely on batch testing, clear expiration dating, and safety seals to prevent contamination—a lesson learned from years of handling emergency drugs.
The main use for Dopamine Hydrochloride comes during states of low blood pressure, especially when the body’s own mechanisms fail to do the job. Septic shock—the most common scenario in many ICUs—often needs more aggressive support than fluids alone. Here, the drug helps bring blood pressure back up, restoring perfusion to vital organs like kidneys, heart, and brain. It also proves useful after major surgery, during cardiac arrest, or in the wake of traumatic injury. Paramedics keep vials in ambulances for precisely these reasons. It’s not the flashiest solution, but with years of use in both children and adults, Dopamine Hydrochloride’s record speaks for itself.
No one drug works for every situation, so the debate often becomes: why pick Dopamine Hydrochloride over alternatives? Take norepinephrine, often now considered the first-line vasopressor in septic shock according to major guidelines. Doctors might switch between the two drugs based on a patient’s response, known allergies, or organ function. Dobutamine, meanwhile, serves as a go-to for severe heart failure where blood pressure isn’t the main problem. Epinephrine gets top billing in cardiac arrest but sometimes brings more side effects than Dopamine Hydrochloride for borderline blood pressure problems. The biggest difference comes down to how each medication targets specific receptors in the heart and blood vessels. Dopamine Hydrochloride offers a middle ground: reliable support with a lower risk of over-tightening blood vessels, especially at moderate doses.
Every drug in the ICU carries risks, and Dopamine Hydrochloride calls for vigilance. Too high a dose sometimes triggers irregular heartbeats or excessive tightening of blood vessels, potentially leading to tissue damage. Nurses and doctors monitor heart rhythms and blood pressure closely during infusions, ready to adjust rates or add medications if unwanted side effects pop up. Research has outlined the ideal dose ranges to balance benefit with risk. Proper use starts with ongoing education. Hospitals update training as new evidence comes to light, striving to keep everyone on the same page about protocols, dilution, and indications.
The story of medical supply reliability often hides behind the scenes until a crisis hits. The COVID-19 pandemic demonstrated how thin the supply chains for key drugs can stretch, and Dopamine Hydrochloride was no exception. Manufacturers that invest in robust quality assurance processes build confidence for frontline teams. Batch testing, secure packaging, and transparent recalls keep quality in check, and regulatory agencies run inspections to keep standards high. Trust is built one vial at a time.
Trends in critical care shift every year as technology advances and new research emerges. For all the newer molecules on the market, Dopamine Hydrochloride holds its ground because it provides dependable clinical effects. It fits a wide range of scenarios: pre-hospital emergency care, perioperative management, shock after sepsis, or cardiac failure. Its cost remains within reach for resource-limited settings, making it invaluable in rural and developing hospitals where expensive alternatives might not be feasible. There are lessons here about not overlooking proven solutions just because something newer grabs headlines.
I remember seeing this drug in action during several busy overnight shifts at a teaching hospital. The speed with which it pulls up blood pressures after a session of sepsis-induced hypotension has meant the difference between kidney failure and recovery for certain patients. Colleagues trust Dopamine Hydrochloride for its predictability and clear impact. When time and certainty matter most, medications without a proven track record fall by the wayside. With Dopamine Hydrochloride, you are dealing with a workhorse, not a wild card.
One ongoing challenge involves making the best choice among competing vasopressors for different types of shock. Guidelines offer direction, but every patient brings unique circumstances. Body habitus, kidney function, and underlying heart disease all influence which agent will serve best. Even though some recent studies recommend norepinephrine ahead of Dopamine Hydrochloride in septic shock, not every patient fits the mold. Public health leaders have to weigh benefits and risks, not just for individuals, but for entire populations. The continuing debate pushes the medical community to gather more data and share real-world experiences to refine recommendations.
To keep patients safer, hospitals prioritize ongoing staff education. Regular training updates ensure everyone knows the latest dosing protocols, how to monitor for side effects, and what to do if an infusion line fails. Pharmacy departments work with medical teams to make labeling clear, provide ready-to-mix kits, and avoid out-of-date stock. At a system level, medical supply chains need back-up plans to avoid shortages, which means governments and suppliers coordinate stockpiles and identify alternative sources long before a problem emerges. International cooperation smooths out kinks in production, transportation, and delivery for essential emergency drugs.
Medicine as a field has changed dramatically with the push toward transparency and shared decision-making. Even for interventions as urgent as Dopamine Hydrochloride infusions, patients or their families want to understand why their loved one received a particular medicine. Healthcare workers have a responsibility to explain not just the hoped-for benefits but also the possible drawbacks. Respecting this transparency helps build trust, reinforces the value of expertise, and gives patients a voice, even during critical moments. This shared process supports better health outcomes and strengthens relationships between staff and families.
Affordability and access to Dopamine Hydrochloride spring up as urgent issues, especially in regions struggling with limited medical resources. Hospitals must weigh budget limits and keep enough stock on hand for emergencies. Equitable access is not just a matter of logistics—it calls for honest conversations about priorities and fairness. The need does not go away when budgets tighten or competitors enter the market. Global health organizations keep tracking core emergency drugs, supporting efforts to keep them available everywhere.
Thinking about tomorrow’s critical care landscape, there’s still a place for Dopamine Hydrochloride. Biotechnology companies might discover new agents or devices to support blood pressure and heart function, but not every answer will replace the tried-and-true. Health systems need strategies that honor both innovation and reliability. Investment in ongoing research, robust distribution networks, and unbiased clinical education forms the backbone of better emergency care worldwide. Listening to experienced nurses and physicians ensures new guidelines make practical sense instead of just theoretical improvements.
Evidence-based medicine works best when driven by reliable clinical trial data and lived experience from day-to-day practice. Hospitals that track patient results with Dopamine Hydrochloride and other drugs develop richer, more nuanced guidelines over time. Publishing outcomes, sharing lessons learned, and synthesizing both success stories and complications help the entire field move forward. No drug works in isolation, so the focus stays on outcomes for real people, not just lab values or charts.
For all its longevity, Dopamine Hydrochloride continues to force important questions about best practice, safety, and resource allocation. When technology evolves, so must the context in which medications get used. Faster bedside monitors, predictive decision support tools, and remote supervision can make use even safer and more effective. Medical schools refine curricula to focus on current protocols, not just tradition, blending experience with new learning. Watching trends in critical care and emergency medicine, I see Dopamine Hydrochloride remaining relevant for many years if we support its use with open communication and a respect for both facts and frontline wisdom.
No medicine replaces the judgement or compassion of a well-trained medical team. Dopamine Hydrochloride, with its proven impact and real-world reliability, remains a prime example of how careful application of science saves lives. Keeping it available, understood, and respected will mean better outcomes not just for those who walk through the doors of major academic hospitals, but also in small clinics wherever urgent care takes place. The story of this medication is not just about chemistry, but about the lived reality of patients, families, and caregivers working together for survival and recovery.